Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas System”

1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,742
Index total 30,257
Page 51 / 73

Quick answer

This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,742 results for “The Board of Regents of the University of Texas System” · 30,257 patents in full index Clear search

  1. US 8258163

    Small-molecule agonists for type-2 orexin receptor

    The Board of Regents of the University of Texas System · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted
  2. US 8252841

    Methods of inhibiting bacterial virulence and compounds relating thereto

    The Board of Regents of the University of Texas System · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted
  3. US 8252836

    Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease

    The Board of Regents of the University of Texas System · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted
  4. US 8252807

    Methods of inhibiting the interaction between S100 and the receptor for advanced glycation end-products

    The Board of Regents of the University of Texas System · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted
  5. US 8252764

    Compositions and methods of use of targeting peptides against placenta and adipose tissues

    The Board of Regents of the University of Texas System · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted
  6. US 8252574

    Pseudoinfectious flavivirus and uses thereof

    The Board of Regents of the University of Texas System · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted
  7. US 8236279

    Bisaminoethanethiol-targeting ligand conjugates and compositions

    The Board of Regents of the University of Texas System · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  8. US 8236983

    Composition and method for the treatment of diseases affected by apoptosis

    The Board of Regents of the University of Texas System · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  9. US 8232068

    Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

    The Board of Regents of the University of Texas System · Granted Jul 31, 2012 · Expires Jul 26, 2032

    granted
  10. US 8216593

    Parasite vaccine

    The Board of Regents of the University of Texas System · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted
  11. US 8216614

    Powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis

    The Board of Regents of the University of Texas System · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted
  12. US 8211941

    Antagonists of the transient receptor potential vanilloid 1 and uses thereof

    The Board of Regents of the University of Texas System · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted
  13. US 8212007

    Expression and purification of HIP/PAP and uses therefor

    The Board of Regents of the University of Texas System · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted
  14. US 8212104

    Model of experimentally induced chronic pain and uses thereof

    The Board of Regents of the University of Texas System · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted
  15. US 8211649

    Methods of diagnosing and prognosing hodgkin's lymphoma

    The Board of Regents of the University of Texas System · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted
  16. US 8211635

    P53 modulator and cancer target

    The Board of Regents of the University of Texas System · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted
  17. US 8206724

    Method and compositions for vaccination comprising nucleic acid and/or polypeptide sequence of chlamydia

    The Board of Regents of the University of Texas System · Granted Jun 26, 2012 · Expires Jun 21, 2032

    granted
  18. US 8202848

    Identification of micro-RNAS involved in neuromuscular synapse maintenance and regeneration

    The Board of Regents of the University of Texas System · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted
  19. US 8198322

    Apoptotic and anti-tumor activities of metallo-salens

    The Board of Regents of the University of Texas System · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted
  20. US 8193152

    Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds

    The Board of Regents of the University of Texas System · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  21. US 8193225

    Isoxazole amides, derivatives and methods of chemical induction of neurogenesis

    The Board of Regents of the University of Texas System · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  22. US 8173115

    Particle compositions with a pre-selected cell internalization mode

    The Board of Regents of the University of Texas System · Granted May 8, 2012 · Expires May 3, 2032

    granted
  23. US 8163709

    TAK1-D mediated induction of cell death in human cancer cells by specific sequence short double-stranded RNAS

    The Board of Regents of the University of Texas System · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  24. US 8163881

    Immunoglobulin molecules with improved characteristics

    The Board of Regents of the University of Texas System · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted